JP2024096897A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024096897A5 JP2024096897A5 JP2024065910A JP2024065910A JP2024096897A5 JP 2024096897 A5 JP2024096897 A5 JP 2024096897A5 JP 2024065910 A JP2024065910 A JP 2024065910A JP 2024065910 A JP2024065910 A JP 2024065910A JP 2024096897 A5 JP2024096897 A5 JP 2024096897A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- polypeptide
- dyw
- editing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025073407A JP7698371B1 (ja) | 2020-03-31 | 2025-04-25 | 標的ｒｎａを編集する方法 |
| JP2025094806A JP2025120313A (ja) | 2020-03-31 | 2025-06-06 | 標的ｒｎａを編集する方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020065065 | 2020-03-31 | ||
| JP2020065065 | 2020-03-31 | ||
| PCT/JP2021/014096 WO2021201198A1 (ja) | 2020-03-31 | 2021-03-31 | 標的ｒｎａを編集する方法 |
| JP2022512682A JP7668547B2 (ja) | 2020-03-31 | 2021-03-31 | 標的ｒｎａを編集する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512682A Division JP7668547B2 (ja) | 2020-03-31 | 2021-03-31 | 標的ｒｎａを編集する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025073407A Division JP7698371B1 (ja) | 2020-03-31 | 2025-04-25 | 標的ｒｎａを編集する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024096897A JP2024096897A (ja) | 2024-07-17 |
| JP2024096897A5 true JP2024096897A5 (enExample) | 2025-05-02 |
| JP7698351B2 JP7698351B2 (ja) | 2025-06-25 |
Family
ID=77930108
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512682A Active JP7668547B2 (ja) | 2020-03-31 | 2021-03-31 | 標的ｒｎａを編集する方法 |
| JP2024065910A Active JP7698351B2 (ja) | 2020-03-31 | 2024-04-16 | 標的ｒｎａを編集する方法 |
| JP2025073407A Active JP7698371B1 (ja) | 2020-03-31 | 2025-04-25 | 標的ｒｎａを編集する方法 |
| JP2025094806A Pending JP2025120313A (ja) | 2020-03-31 | 2025-06-06 | 標的ｒｎａを編集する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512682A Active JP7668547B2 (ja) | 2020-03-31 | 2021-03-31 | 標的ｒｎａを編集する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025073407A Active JP7698371B1 (ja) | 2020-03-31 | 2025-04-25 | 標的ｒｎａを編集する方法 |
| JP2025094806A Pending JP2025120313A (ja) | 2020-03-31 | 2025-06-06 | 標的ｒｎａを編集する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230125942A1 (enExample) |
| EP (1) | EP4130274A4 (enExample) |
| JP (4) | JP7668547B2 (enExample) |
| KR (1) | KR20220165747A (enExample) |
| CN (1) | CN115698296A (enExample) |
| AU (1) | AU2021248204A1 (enExample) |
| BR (1) | BR112022019571A2 (enExample) |
| CA (1) | CA3179365A1 (enExample) |
| IL (1) | IL296955A (enExample) |
| TW (1) | TWI899197B (enExample) |
| WO (1) | WO2021201198A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3216313A1 (en) * | 2021-04-30 | 2022-11-03 | Masayuki NAKAMORI | Myotonic dystrophy type 1 therapeutic drug |
| JPWO2023120658A1 (enExample) * | 2021-12-24 | 2023-06-29 | ||
| WO2024249445A2 (en) * | 2023-05-26 | 2024-12-05 | The Trustees Of Columbia University In The City Of New York | An rna recognition and editing code of pentatricopeptide repeat proteins |
| CN117384884B (zh) * | 2023-11-30 | 2024-03-08 | 辉大(上海)生物科技有限公司 | IscB多肽及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009134339A2 (en) * | 2008-04-29 | 2009-11-05 | Monsanto Technology, Llc | Genes and uses for plant enhancement |
| DK2784157T3 (da) * | 2011-10-21 | 2019-10-21 | Univ Kyushu Nat Univ Corp | Designfremgangsmåde til et rna-bindende protein under anvendelse af ppr-motiv og anvendelse deraf |
| AU2014258386B2 (en) | 2013-04-22 | 2018-10-25 | Hiroshima University | DNA binding protein using PPR motif, and use thereof |
-
2021
- 2021-03-31 WO PCT/JP2021/014096 patent/WO2021201198A1/ja not_active Ceased
- 2021-03-31 KR KR1020227037296A patent/KR20220165747A/ko active Pending
- 2021-03-31 CN CN202180037500.0A patent/CN115698296A/zh active Pending
- 2021-03-31 TW TW110112005A patent/TWI899197B/zh active
- 2021-03-31 AU AU2021248204A patent/AU2021248204A1/en active Pending
- 2021-03-31 IL IL296955A patent/IL296955A/en unknown
- 2021-03-31 US US17/915,232 patent/US20230125942A1/en active Pending
- 2021-03-31 BR BR112022019571A patent/BR112022019571A2/pt unknown
- 2021-03-31 EP EP21781411.0A patent/EP4130274A4/en active Pending
- 2021-03-31 CA CA3179365A patent/CA3179365A1/en active Pending
- 2021-03-31 JP JP2022512682A patent/JP7668547B2/ja active Active
-
2024
- 2024-04-16 JP JP2024065910A patent/JP7698351B2/ja active Active
-
2025
- 2025-04-25 JP JP2025073407A patent/JP7698371B1/ja active Active
- 2025-06-06 JP JP2025094806A patent/JP2025120313A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024096897A5 (enExample) | ||
| Garcia-Barreno et al. | Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions | |
| JP2023506765A5 (enExample) | ||
| Fisher et al. | Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization | |
| Zhang et al. | Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein | |
| JP2023082054A5 (enExample) | ||
| JP2017018125A5 (enExample) | ||
| JP2023179457A5 (enExample) | ||
| JP2024520868A5 (enExample) | ||
| JP2019536462A5 (enExample) | ||
| JP2023528204A5 (enExample) | ||
| Kadereit et al. | Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. | |
| Blixenkrone-Möller et al. | Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript | |
| JP2023529844A5 (enExample) | ||
| BR112022019571A2 (pt) | Método para editar um ácido ribonucleico alvo, domínio dyw, proteína dyw, composição para editar ácido ribonucleico em uma célula eucariótica, ácido nucleico, vetor, e, célula | |
| US20130273606A1 (en) | Secretion yield of a protein of interest by in vivo proteolytic processing of a multimeric precursor | |
| CA2230111A1 (en) | Antisecretory factor peptides regulating pathological permeability changes | |
| DK200601181A (da) | Fiskevaccine | |
| JP2024503091A5 (enExample) | ||
| JP2004532037A5 (enExample) | ||
| ES2290156T3 (es) | Vector de expresion y secrecion del alfa interferon humano y procedimiento para producir alfa interferon humano empleando el anterior. | |
| JP2023075230A5 (enExample) | ||
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| Fujio et al. | Induction of mRNAs for heat shock proteins in livers of rats after ischemia and partial hepatectomy | |
| JP2005535289A5 (enExample) |